Glycominds Ltd. Company Profile

Glycominds, a commercial stage molecular diagnostics company, develops and commercializes autoimmune and chronic inflammatory disease management tools and services with a distinctive focus on the Multiple Sclerosis market. Our proprietary tests allow physicians to help identify patients at a higher risk for more severe disease outcomes.

More Information about "Glycominds Ltd." on BioPortfolio

We have published hundreds of Glycominds Ltd. news stories on BioPortfolio along with dozens of Glycominds Ltd. Clinical Trials and PubMed Articles about Glycominds Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glycominds Ltd. Companies in our database. You can also find out about relevant Glycominds Ltd. Drugs and Medications on this site too.